Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
ALAlamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR)

NASDAQ Global Select · Currency in USD
$30.69 ▲ +0.97 (+3.26%)
At close: Oct 23, 4:00 PM ET. Market closed.
$30.63 ▼ -0.06 (-0.20%)
After hours: Oct 23, 7:42 PM ET

Summary

Previous Close
$29.72
Open
$29.65
Day's Range
$28.61 – $31.46
52 Week Range
$18.85 – $39.61
Volume
748,226
Avg. Volume
473,692
Market Cap
$2.13B
Beta (5Y Monthly)
-6.18
PE Ratio (TTM)
--
EPS (TTM)
-$0.59
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$33.50

Profile: Alamar Biosciences, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
222
CEO
Yuling Luo
Website
--

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.20 · Revenue est. $30.22M
DateEst.Actual
Aug 10, 2026-$0.31-$0.22Beat
May 8, 2026-$1.71-$1.74Miss

Analyst view

Consensus price target
$33.50 ▲ +9.2%
Range $32.00 – $35.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on ALMR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.